-
公开(公告)号:US20060079469A1
公开(公告)日:2006-04-13
申请号:US10493486
申请日:2002-10-25
Applicant: Erik Anderson , Trung Le Doan , Laurent Lamidey
Inventor: Erik Anderson , Trung Le Doan , Laurent Lamidey
IPC: A61K48/00
CPC classification number: A61L31/16
Abstract: An anti-restenosis agent comprises a phosphorothioate-modified oligonucleotide includes at least on hairpin loop and a TG sequence. The hairpin loop preferably has the sequence CAG CGA AGC. Especially preferred oligonucleotides are ones which include a sequence selected from TGGGG TGGGG T GGGGT GGGGT CAG CGA AGC (SEQ ED NO: 4) and TTGGG TTGGG T GGGTT GGGTT CAG CGA AGC (SEQ TD NO: 6). The anti-restenosis agent may be used as or in a coating on a device for implantation into the body, for instance a stent.
Abstract translation: 抗再狭窄剂包含至少在发夹环和TG序列上的硫代磷酸酯修饰的寡核苷酸。 发夹环优选具有序列CAG CGA AGC。 特别优选的寡核苷酸是包括选自TGGGG TGGGG T GGGGT GGGGT CAG CGA AGC(SEQ ID NO:4)和TTGGG TTGGG T GGGTT GGGTT CAG CGA AGC(SEQ ID NO:6)的序列的寡核苷酸。 抗再狭窄剂可以用作植入装置中用于植入体内的涂层,例如支架。